Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials

Journal of Hypertension
Heather O DickinsonGary A Ford

Abstract

To quantify effectiveness of lifestyle interventions for hypertension. Electronic bibliographic databases from 1998 onwards, existing guidelines, systematic reviews. We included randomized, controlled trials with at least 8 weeks' follow-up, comparing lifestyle with control interventions, enrolling adults with blood pressure at least 140/85 mmHg. Primary outcome measures were systolic and diastolic blood pressure. Two independent reviewers selected trials and abstracted data; differences were resolved by discussion. We categorized trials by type of intervention and used random effects meta-analysis to combine mean differences between endpoint blood pressure in treatment and control groups in 105 trials randomizing 6805 participants. Robust statistically significant effects were found for improved diet, aerobic exercise, alcohol and sodium restriction, and fish oil supplements: mean reductions in systolic blood pressure of 5.0 mmHg [95% confidence interval (CI): 3.1-7.0], 4.6 mmHg (95% CI: 2.0-7.1), 3.8 mmHg (95% CI: 1.4-6.1), 3.6 mmHg (95% CI: 2.5-4.6) and 2.3 mmHg (95% CI: 0.2-4.3), respectively, with corresponding reductions in diastolic blood pressure. Relaxation significantly reduced blood pressure only when compared with n...Continue Reading

References

Mar 1, 1977·Archives of General Psychiatry·C B TaylorS Agras
Jun 1, 1978·Psychosomatic Medicine·B L FrankelK R Gaarder
Jan 1, 1979·Journal of Applied Behavior Analysis·E B BlanchardR Wicker
Jan 1, 1992·Cardiology·L A FerraraM Mancini
Jan 1, 1992·Psychosomatic Medicine·R G JacobY Ding
Jun 1, 1992·Archives of Internal Medicine·W B ApplegateM J Graney
Oct 1, 1991·American Journal of Hypertension·Y TakagiT Fujita
Nov 1, 1991·Psychosomatic Medicine·M J Irvine, A G Logan
Feb 1, 1991·The American Journal of Clinical Nutrition·G MargolinT Tracy
Jan 1, 1991·Journal of Psychosomatic Research·P BennettN Smith
Apr 1, 1990·Journal of Hypertension·L M WingA E Russell
Apr 1, 1990·The American Journal of Clinical Nutrition·P C ZemelJ R Sowers
May 1, 1990·Circulation·J E MartinW C Cushman
Jun 1, 1990·Journal of Internal Medicine·A JulaJ Mäki
May 26, 1990·BMJ : British Medical Journal·G A van MontfransA J Dunning
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·Y TanabeK Arakawa
Apr 1, 1989·Clinical and Experimental Pharmacology & Physiology·C A Nowson, T O Morgan
Feb 1, 1989·Journal of Behavioral Medicine·F Bosley, T W Allen
Aug 1, 1989·The American Journal of Cardiology·J M HagbergA A Ehsani
May 28, 1988·British Medical Journal·J J BeutlerG G Geijskes
Dec 1, 1988·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·A KinoshitaK Arakawa
Mar 1, 1988·Journal of Clinical Psychology·R LaGroneC L Ferguson
Jan 1, 1988·Behavioral Medicine·M A CarsonB M McKay
Jan 1, 1986·Journal of Psychosomatic Research·M J IrvineG V Marie

❮ Previous
Next ❯

Citations

Jul 12, 2008·Journal of Behavioral Medicine·Eric B HeklerRichard J Contrada
May 7, 2011·Journal of Community Health·Jan Warren-FindlowLarissa R Brunner Huber
Oct 27, 2009·Journal of General Internal Medicine·Andrea BersaminMarilyn A Winkleby
May 10, 2013·Internal and Emergency Medicine·Luca MontesiGiulio Marchesini
Mar 20, 2008·Current Hypertension Reports·Maxwell V RainforthJames W Anderson
Oct 31, 2013·Current Hypertension Reports·Bruce NealMark Woodward
Oct 9, 2013·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·N YazdekhastiM Taheri
Jun 7, 2006·The Canadian Journal of Cardiology·R M Touyz, UNKNOWN Canadian Hypertension Education Program
Jun 13, 2008·Journal of Human Hypertension·Ho DickinsonJm Mason
Apr 16, 2010·Journal of Human Hypertension·T ScheltensM L Bots
Jan 11, 2012·Antioxidants & Redox Signaling·Dao-Fu DaiPeter S Rabinovitch
Oct 13, 2011·European Heart Journal·Tiberio M FrisoliFranz H Messerli
May 10, 2008·Rheumatology·V F PanoulasG D Kitas
Feb 24, 2007·The Journal of Cardiovascular Nursing·Beth A StaffilenoSteven M Hollenberg
Jan 10, 2014·The Journal of Ambulatory Care Management·Douglas W RoblinStacey A Benjamin
Jan 16, 2007·Current Opinion in Lipidology·Valerie H Myers, Catherine M Champagne
Feb 7, 2009·International Journal of Clinical Practice·T VogelJ Lonsdorfer
Aug 2, 2011·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Scott G ThomasJamie F Burr
Nov 13, 2010·Kidney & Blood Pressure Research·I Drenjančević-PerićM Gros
Oct 1, 2008·Hypertension·Karen L MargolisUNKNOWN Women's Health Initiative Investigators
Sep 22, 2007·BMC Public Health·Esther W de Bekker-GrobWillem Jan Meerding
Dec 25, 2007·BMC Health Services Research·James E RohrerJoseph W Furst
May 13, 2010·The International Journal of Behavioral Nutrition and Physical Activity·Darren Er WarburtonShannon Sd Bredin
Sep 12, 2012·The International Journal of Behavioral Nutrition and Physical Activity·Sanjoti ParekhFrances M Boyle
Apr 7, 2009·PloS One·Janet ChamberlainDavid C Crossman
Jul 23, 2013·PloS One·Shiu Lun Au YeungC Mary Schooling
Jul 12, 2012·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·J G MillS L Rodrigues
Jun 6, 2012·International Journal of Chronic Obstructive Pulmonary Disease·W Darlene ReidPat G Camp
Mar 16, 2011·International Journal of General Medicine·Meghan BaruthSteven N Blair
Oct 1, 2008·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Daniele VersariAntonio Salvetti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.